Press Releases

On January 1, 2021, the Berlin Institute of Health (BIH ) will become the translational research unit of Charité – Universitätsmedizin Berlin and will then form – alongside the hospital and the medical faculty – Charité’s third pillar.

Berlin will become one of four new National Center for Tumor Diseases (NCT) locations in addition to Heidelberg and Dresden. This was announced today by the Federal Ministry of Education and Research, recognizing the outstanding achievements of Charité, the BIH and the MDC in advancing cancer treatment and research.

Researchers at the MDC have developed a new online tool that displays the development of the COVID-19 epidemic in Germany clearly and by individual state as well as worldwide. The map and timeline showing the spread of the coronavirus are freely available on the internet.

Research groups from Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC) are joining forces with other Berlin-based partners. Pooling their experience and outstanding expertise in the field of mass spectrometry, they will form a new ‘Forschungskern’ or ‘research core’.

As Karl Max Einhäupl steps down as Chairman of the Charité’s Executive Board, Thomas Sommer, interim Scientific Director of the MDC, honors Einhäupl’s achievements and applauds him for the excellent and equitable collaboration. Sommer wishes the Charité’s new head, Heyo Kroemer, the very best and much success in his new position.

The administrative agreement is signed, the Berlin Institute of Health (BIH ) will become the third pillar of the Charité. "We are excited about the privileged partnership," says Professor Thomas Sommer, interim Scientific Director of the MDC.

The MDC welcomes the agreement reached between the State of Berlin and the federal government regarding the future of the Berlin Institute of Health (BIH ). The term “privileged partnership” has to now be filled with life and backed up with funding.

LifeTime is one of the six winners of an EU-wide competition in which ambitious and forward-looking research projects are selected and funded. This was officially announced by the European Commission on Tuesday. The coordinators of LifeTime in Berlin and Paris were pleased that they can now begin the actual work. Chancellor Merkel praised the initiative.

Chancellor Angela Merkel inaugurated on Tuesday the Max Delbrück Center’s new building in the heart of Berlin. Some 250 top researchers of the Berlin Institute for Medical Systems Biology (BIMSB) will use the facility to study how genes regulate the lives of cells and thus influence health and disease.

Jutta Kramm took over on October 1, 2018, as head of the Communications Department at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC). Kramm, 59, was previously a PR manager and spokesperson at the children’s rights organization Save the Children Germany.